A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants
Under a Creative Commons license
open access
Keywords
Neisseria meningitidis serogroup B
Factor H-binding protein
LP2086
Infants
Cited by (0)
Copyright © 2014 Published by Elsevier Ltd.